Reports >
Life Sciences
>
Biobanking Market Report
Biobanking Market Report
First published: 10 October 2024 | Last updated: 22 April 2026 | Report Code: biobanking
Biobanking Market — USD 10 billion in 2023, Growing to USD 17.29B by 2033 at 5.5% CAGR
This report provides an in-depth analysis of the global biobanking market, encompassing trends, forecasts, and insights tailored for the period from 2023 to 2033. It highlights critical data points, regional dynamics, and industry analysis essential for stakeholders in the biobanking sector.
Key Takeaways
- Global value rises from $10.00 Billion in 2023 to $17.29 Billion in 2033, reflecting a 5.5% CAGR across the forecast period.
- North America is both the largest and fastest-growing market, increasing from $3.63 Billion to $6.28 Billion between 2023 and 2033.
- Europe grows from $3.25 Billion to $5.62 Billion while Asia Pacific advances from $1.85 Billion to $3.2 Billion over the decade.
- Demand from hospitals, academic institutions, pharmaceutical and biotechnology companies is driving investments in storage, analysis, and data solutions.
- Market competition includes BD Biosciences, Thermo Fisher Scientific, Qiagen, Eppendorf AG, and VWR International LLC, focusing on integrated biobanking offerings.
Biobanking Market Report — Executive Summary
The biobanking market is on a sustained expansion path, moving from $10.00 Billion in 2023 to $17.29 Billion by 2033 at a 5.5% CAGR over 2023 to 2033. Growth is fueled by rising sample-driven research, uptake of advanced preservation methods, and heightened data management needs across healthcare and life-science research. North America leads the landscape in scale and pace, supported by established infrastructures and institutional demand. Europe and Asia Pacific are notable contributors, with Europe expanding from $3.25 Billion to $5.62 Billion and Asia Pacific from $1.85 Billion to $3.2 Billion. Primary end users include hospitals, academic institutions, pharmaceutical and biotechnology companies, necessitating solutions that span sample collection, storage, analysis, and informatics. Technology trends emphasize automated storage systems, enhanced sample integrity methods, and data platforms to handle complex biospecimen information. Key vendors such as BD Biosciences and Thermo Fisher Scientific are investing in integrated services to meet compliance and research needs. The report is structured to cover market sizing, segment performance, regional dynamics, and vendor positioning to inform stakeholders and strategic decision-making.
Key Growth Drivers
- Expansion of genomics and personalized medicine research raising demand for well-characterized biospecimens and long-term storage.
- Improved sample preservation and automated storage technologies increasing throughput and reducing handling risks for biobanks.
- Stronger collaboration between biobanks, research institutions, and industry accelerating sample sharing for diagnostics and therapeutic development.
- Growing emphasis on data management and bioinformatics to link specimen information with clinical and research datasets.
- Increased funding for clinical studies and research programs driving acquisition and retention of diverse biomaterial collections.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $10.00 Billion |
| CAGR (2023-2033) | 5.5% |
| 2033 Market Size | $17.29 Billion |
| Top Companies | BD Biosciences, Thermo Fisher Scientific, Qiagen , Eppendorf AG, VWR International LLC |
| Published Date | 10 October 2024 |
| Last Modified Date | 22 April 2026 |
Biobanking Market Overview
Customize Biobanking Market Report market research report
- ✔ Get in-depth analysis of Biobanking market size, growth, and forecasts.
- ✔ Understand Biobanking's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Biobanking
What is the Market Size & CAGR of Biobanking Market Report market in 2023?
Biobanking Industry Analysis
Biobanking Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Biobanking Market Report Market Analysis Report by Region
Europe Biobanking Market Report:
Europe grows from $3.25 Billion in 2023 to $5.62 Billion in 2033. Regional expansion is supported by academic research programs, clinical study activity, and regulatory emphasis on specimen quality and consent processes driving investment in storage and data platforms.Asia Pacific Biobanking Market Report:
Asia Pacific increases from $1.85 Billion in 2023 to $3.2 Billion in 2033. Growth is driven by rising research funding, expanding clinical trials, and adoption of modern preservation and analytics technologies across hospitals and academic centers.North America Biobanking Market Report:
North America is both the largest and fastest-growing market, expanding from $3.63 Billion in 2023 to $6.28 Billion in 2033. Growth is underpinned by established clinical and research infrastructures, strong institutional demand, and active participation from vendors such as Thermo Fisher Scientific and BD Biosciences.South America Biobanking Market Report:
Middle East & Africa Biobanking Market Report:
Middle East and Africa expand from $0.67 Billion in 2023 to $1.16 Billion in 2033. Development is propelled by increasing healthcare research initiatives, investments in biorepository capabilities, and collaborations with international research organizations.Tell us your focus area and get a customized research report.
Research Methodology
Biobanking Market Analysis By Biomaterial
In terms of biomaterials, the biobanking market is significantly driven by blood samples, which accounted for $6.52 billion in 2023 and is forecasted to grow to $11.28 billion by 2033. Tissue samples and organ samples also play pivotal roles, with tissue samples generating $2.20 billion in 2023 and expected to reach $3.80 billion by 2033, while organ samples projected to grow from $1.28 billion to $2.22 billion in the same timeframe.
Biobanking Market Analysis By Application
The research application in the biobanking market is prominent, valued at approximately $6.52 billion in 2023 and projected to reach $11.28 billion by 2033. Diagnostics and therapeutics follow suit, with diagnostics starting at $2.20 billion and expected to rise to $3.80 billion, while therapeutics will grow from $1.28 billion to $2.22 billion during the same period.
Biobanking Market Analysis By Storage Type
Preferring frozen storage technology, the market is estimated at $6.52 billion in 2023, projected to increase to $11.28 billion by 2033. Meanwhile, room temperature storage holds a market size of $2.20 billion and is expected to grow to $3.80 billion, emphasizing the varied methodologies of sample preservation available in biobanking.
Biobanking Market Analysis By End User
Hospitals dominate the biobanking market, representing a value of $5.42 billion in 2023 with a forecasted rise to $9.37 billion by 2033. Academic institutions and pharmaceutical companies hold significant shares too, contributing $2.13 billion and $1.38 billion in 2023, respectively. Their importance is underscored by their roles in research and therapeutic developments.
Biobanking Market Analysis By Region
Technology-driven analysis indicates that sample collection technologies command a substantial share of the market, valued at $5.42 billion in 2023, projected to reach $9.37 billion by 2033. Data management solutions are also pivotal, growing from $1.07 billion to $1.86 billion, reflecting the technological advancements in biobanking.
Biobanking Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Biobanking Industry
BD Biosciences:
A leader in the development of innovative technologies for the collection and preparation of biological samples, BD Biosciences provides solutions that enhance the efficiency of biobanks globally.Thermo Fisher Scientific:
Known for its extensive portfolio of biobank reagents and equipment, Thermo Fisher Scientific is at the forefront of biobanking technology, enabling researchers to accelerate their studies.Qiagen :
Qiagen specializes in sample and assay technologies, providing integrated solutions that are essential for biobanking, including sample preparation and management tools.Eppendorf AG:
Eppendorf is renowned for its laboratory equipment and accessories, including solutions that support the cooling and preservation of biological samples in biobanks.VWR International LLC:
A global leader in laboratory supplies and equipment, VWR offers a broad range of products and services tailored for the needs of biobanks and their operations.We're grateful to work with incredible clients.
FAQs
What is the current market size of the biobanking sector?
The market size was $10.00 Billion in 2023, representing the baseline for projected expansion to $17.29 Billion by 2033 under the forecast period described in the report.
How big is the projected market by 2033?
By 2033 the market is projected to reach $17.29 Billion, reflecting growth driven by increased research activity, improved preservation methods, and expanded data management requirements.
What is CAGR for the forecast period?
The market is expected to grow at a compound annual growth rate of 5.5% during the forecast period from 2023 to 2033, reflecting steady, long-term expansion.
Which region is the largest market?
North America is the largest region, with its market expanding from $3.63 Billion in 2023 to $6.28 Billion by 2033, supported by institutional infrastructure and research demand.
Why is North America the fastest Growing region?
North America leads in growth due to concentrated research investment, established biobanking infrastructures, and demand from hospitals, academic institutions, and industry partners.
Who are the key companies active in the market?
Leading organizations include BD Biosciences, Thermo Fisher Scientific, Qiagen, Eppendorf AG, and VWR International LLC, offering solutions across storage, processing, and data management.
What end users drive demand for biobanking services?
Primary end users comprise hospitals, academic institutions, pharmaceutical companies, and biotechnology firms, which require specimen collection, storage, and analysis capabilities for research and clinical use.
How big is the Europe market and its trajectory?
Europe's market increases from $3.25 Billion in 2023 to $5.62 Billion in 2033, influenced by research funding, regulatory frameworks, and adoption of advanced storage and data solutions.
What role does data management play in market growth?
Data management is central, enabling linkage of specimen metadata with clinical and research datasets; this demand is driving investment in bioinformatics and secure repository platforms.